Nu Skin Enterprises (NYSE: NUS) — Perfil da empresa, notícias e dados financeiros
Nu Skin Enterprises is a global direct selling company offering premium beauty and wellness products with a focus on sustainability.
Nu Skin Enterprises
Nu Skin Enterprises (NYSE:NUS) is a global direct selling company with a focus on developing and distributing premium-quality beauty and wellness products. It operates in multiple countries around the world, offering a wide range of personal care products and dietary supplements under its Nu Skin and Pharmanex brands. The company is committed to innovation and sustainability, constantly seeking new ways to improve its product offerings and reduce its environmental footprint. Nu Skin is also known for its social impact programs, aiming to improve lives through its corporate social responsibility initiatives, which include nourishing children and empowering individuals and communities. Through its global sales force, Nu Skin strives to create a lasting positive impact by empowering people to look, feel, and live their best lives.
Resumo
Operações
Produtos e/ou serviços de Nu Skin Enterprises
- ageLOC LumiSpa - a dual-action skin renewal and deep cleansing device.
- ageLOC Me - personalized skincare system delivering customized anti-aging solutions.
- Epoch - a line of products inspired by ancient traditions and featuring indigenous ingredients.
- Pharmanex - a range of nutritional supplements aimed at promoting overall health and wellness.
- ageLOC R2 - designed to rejuvenate and detoxify for a youthful appearance.
- Tru Face Essence Ultra - helps firm the skin and enhance facial contours.
equipe executiva do Nu Skin Enterprises
- Steven J. LundCo-Founder & Executive Chairman of the Board
- Ryan S. NapierskiPresident, CEO & Director
- Chayce David ClarkExecutive VP, COO & Chief Legal Officer
- Justin S. KeiselExecutive VP & President of Global Sales (Leave of Absence)
- Blake M. RoneyFounder
- Sandra N. TillotsonFounder
- Chelsea LantzChief Financial Officer
- Joe SueperSenior VP & CTO
- Joseph Y. ChangExecutive VP, Chief Scientific Officer & Chair of Scientific Advisory Board
- B.G. HuntVP of Treasurer, Investor Relations & Admin Services
Histórico de dividendos
Dividendos por ação pagos pela Nu Skin Enterprises, por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $0.1800 |
| FY2025 | — | — | — | $0.2400 |
| FY2024 | — | — | — | $0.2400 |
| FY2023 | — | — | — | $1.5600 |
| FY2022 | — | — | — | $1.5400 |
Principais indicadores financeiros
Resultados divulgados pela Nu Skin Enterprises, em USD.
- Cap. de mercado
- 230,2 mi
- Receita (TTM)
- 1,4 bi
- P/L
- —
- LPA (diluído, TTM)
- -4.5
- Dividend yield
- 5.1%
- Margem de lucro
- -15.7%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,5 bi | 90,9 mi | 160,2 mi | |
| 1,7 bi | -151,6 mi | -146,6 mi | |
| 2 bi | 48,3 mi | 8,6 mi | |
| 2,2 bi | 110,8 mi | 104,8 mi |